Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2023 Earnings Call Transcript

Revolution Medicines, Inc. (NASDAQ:RVMD) Q2 2023 Earnings Call Transcript August 8, 2023

Revolution Medicines, Inc. misses on earnings expectations. Reported EPS is $-0.92 EPS, expectations were $0.83.

Operator: Good day and thank you for standing by. Welcome to Revolution Medicine’s Second Quarter 2023 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers’ presentation, there will be a question-and-answer session. [Operator Instructions]...